Annual report pursuant to Section 13 and 15(d)

Summary of significant accounting policies (Details) - Amount of expense related to share-based payment arrangements

v3.19.3
Summary of significant accounting policies (Details) - Amount of expense related to share-based payment arrangements - USD ($)
$ in Thousands
12 Months Ended
Jul. 31, 2019
Jul. 31, 2018
Jul. 31, 2017
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Share Based Compensation $ 939 $ 813 $ 831
Cost of Clinical Laboratory Services [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Share Based Compensation     6
Selling, General and Administrative Expenses [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Share Based Compensation $ 939 $ 813 $ 825